Percutaneous PFO closure in adult patient with Ebstein anomaly and cyanosis

Ebstein anomaly is a congenital malformation of the tricuspid valve (TV) that is rarely diagnosed in adult population. It is associated with interatrial communication whether by an atrial septal defect (ASD) or parent foramen oval (PFO) in 80–90% of patients. In non surgical candidates, percutaneous...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zahra Nassereddine, MD, Fida Charif, MD, Claudette Najjar, MD, Dani Youssef, MD, Mohamad Saab, MD
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Ebstein anomaly Right to left shunt Congenital heart defect Right heart failure Percutaneous closure Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/cc1f7f1d1820474984476717af4c0838
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:cc1f7f1d1820474984476717af4c0838
record_format	dspace
spelling	oai:doaj.org-article:cc1f7f1d1820474984476717af4c08382021-11-06T04:38:05ZPercutaneous PFO closure in adult patient with Ebstein anomaly and cyanosis2666-668510.1016/j.ijcchd.2021.100221https://doaj.org/article/cc1f7f1d1820474984476717af4c08382021-10-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2666668521001452https://doaj.org/toc/2666-6685Ebstein anomaly is a congenital malformation of the tricuspid valve (TV) that is rarely diagnosed in adult population. It is associated with interatrial communication whether by an atrial septal defect (ASD) or parent foramen oval (PFO) in 80–90% of patients. In non surgical candidates, percutaneous closure of the interatrial communication is not always tolerated. Herein we present the case of 61 year-old man who was diagnosed with Ebstein anomaly that was associated with large patent foramen oval resulting in right to left shunt and causing dyspnea, exercise intolerance and peripheral cyanosis which was not corrected with oxygen administration. Our patient was treated with percutaneous closure of PFO by deployment of Amplatzer septal occluder. We noted a dramatic improvement of the pulse oxygen saturation while in the catheterization laboratory and marked clinical improvement of the dyspnea and exercise tolerance at 2 and 4 week follow-up.Zahra Nassereddine, MDFida Charif, MDClaudette Najjar, MDDani Youssef, MDMohamad Saab, MDElsevierarticleEbstein anomalyRight to left shuntCongenital heart defectRight heart failurePercutaneous closureDiseases of the circulatory (Cardiovascular) systemRC666-701ENInternational Journal of Cardiology Congenital Heart Disease, Vol 5, Iss , Pp 100221- (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ebstein anomaly Right to left shunt Congenital heart defect Right heart failure Percutaneous closure Diseases of the circulatory (Cardiovascular) system RC666-701
spellingShingle	Ebstein anomaly Right to left shunt Congenital heart defect Right heart failure Percutaneous closure Diseases of the circulatory (Cardiovascular) system RC666-701 Zahra Nassereddine, MD Fida Charif, MD Claudette Najjar, MD Dani Youssef, MD Mohamad Saab, MD Percutaneous PFO closure in adult patient with Ebstein anomaly and cyanosis
description	Ebstein anomaly is a congenital malformation of the tricuspid valve (TV) that is rarely diagnosed in adult population. It is associated with interatrial communication whether by an atrial septal defect (ASD) or parent foramen oval (PFO) in 80–90% of patients. In non surgical candidates, percutaneous closure of the interatrial communication is not always tolerated. Herein we present the case of 61 year-old man who was diagnosed with Ebstein anomaly that was associated with large patent foramen oval resulting in right to left shunt and causing dyspnea, exercise intolerance and peripheral cyanosis which was not corrected with oxygen administration. Our patient was treated with percutaneous closure of PFO by deployment of Amplatzer septal occluder. We noted a dramatic improvement of the pulse oxygen saturation while in the catheterization laboratory and marked clinical improvement of the dyspnea and exercise tolerance at 2 and 4 week follow-up.
format	article
author	Zahra Nassereddine, MD Fida Charif, MD Claudette Najjar, MD Dani Youssef, MD Mohamad Saab, MD
author_facet	Zahra Nassereddine, MD Fida Charif, MD Claudette Najjar, MD Dani Youssef, MD Mohamad Saab, MD
author_sort	Zahra Nassereddine, MD
title	Percutaneous PFO closure in adult patient with Ebstein anomaly and cyanosis
title_short	Percutaneous PFO closure in adult patient with Ebstein anomaly and cyanosis
title_full	Percutaneous PFO closure in adult patient with Ebstein anomaly and cyanosis
title_fullStr	Percutaneous PFO closure in adult patient with Ebstein anomaly and cyanosis
title_full_unstemmed	Percutaneous PFO closure in adult patient with Ebstein anomaly and cyanosis
title_sort	percutaneous pfo closure in adult patient with ebstein anomaly and cyanosis
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/cc1f7f1d1820474984476717af4c0838
work_keys_str_mv	AT zahranassereddinemd percutaneouspfoclosureinadultpatientwithebsteinanomalyandcyanosis AT fidacharifmd percutaneouspfoclosureinadultpatientwithebsteinanomalyandcyanosis AT claudettenajjarmd percutaneouspfoclosureinadultpatientwithebsteinanomalyandcyanosis AT daniyoussefmd percutaneouspfoclosureinadultpatientwithebsteinanomalyandcyanosis AT mohamadsaabmd percutaneouspfoclosureinadultpatientwithebsteinanomalyandcyanosis
_version_	1718443882875715584

Percutaneous PFO closure in adult patient with Ebstein anomaly and cyanosis

Ejemplares similares